agreed, I thought the sp was cheap, EPS 3 cents +, more deals to be made, lots of cash, good board of directors with relation to majors. Dont know why the retail shares are so unloved.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025